Date Field | Doc. No. | Description (Pages) |
---|
Jun 9, 2024 | 0 | ASTELLAS PHARMA, INC. v. LUPIN LTD. [ORDER] [nonprecedential] (0) |
Jun 5, 2024 | 11 | Joint Stipulation of Voluntary Dismissal for Appellants Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. and Astellas Pharma, Inc.. Service: 06/05/2024 by email. [1008892] [24-1766] [Daniel Silver] [Entered: 06/05/2024 10:18 AM] (2) |
Jun 5, 2024 | 12 | ORDER voluntarily dismissing appeal pursuant to FRAP 42(b); issuing mandate. Service as of this date by the Clerk of Court. [1009147] [MMA] [Entered: 06/05/2024 04:34 PM] (2) |
May 31, 2024 | 9 | Notice to Appellants Astellas Ireland Co., Ltd., Astellas Pharma Global Development, Inc. and Astellas Pharma, Inc.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 47.6 has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [1007986] [MMA] [Entered: 05/31/2024 04:09 PM] (0) |
May 31, 2024 | 10 | Notice to Appellees Zydus Lifesciences Ltd. and Zydus Pharmaceuticals (USA) Inc.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), Certificate of Interest under FCR 47.4, and/or Docketing Statement under FCR 47.6 has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [1007988] [MMA] [Entered: 05/31/2024 04:13 PM] (0) |
May 14, 2024 | 6 | NOTICE OF NON-COMPLIANCE: The submission of Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc., Entry of Appearance [2], is not in compliance with the rules of this court (see attached). Compliant document due on 05/21/2024. Service as of this date by the Clerk of Court. [1004034] [IMH] [Entered: 05/14/2024 11:14 AM] (2) |
May 14, 2024 | 7 | Amended notice of appeal, amended docket sheet, order, and document from United States District Court for the District of Delaware. [1004064] [MMA] [Entered: 05/14/2024 12:13 PM] (39) |
May 14, 2024 | 8 | Corrected Entry of Appearance for William Zimmerman; Carol Pitzel Cruz; Andrea Cheek as counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 05/14/2024 by email. [1004153] [24-1766] [William Zimmerman] [Entered: 05/14/2024 07:17 PM] (2) |
May 10, 2024 | 2 | Entry of Appearance for William Zimmerman; Carol Pitzel Cruz; Andrea Cheek as counsel for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 05/10/2024 by email. [1003629] [24-1766] . This document is non-compliant. See Doc No.[6] [William Zimmerman] [Entered: 05/10/2024 05:50 PM] (2) |
May 10, 2024 | 3 | Docketing Statement for the Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 05/10/2024 by email. [1003630] [24-1766] [William Zimmerman] [Entered: 05/10/2024 05:52 PM] (2) |
May 10, 2024 | 4 | Certificate of Interest for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 05/10/2024 by email. [1003631] [24-1766] [William Zimmerman] [Entered: 05/10/2024 05:54 PM] (4) |
May 10, 2024 | 5 | Notice of Related Case Information for Appellees Lupin Ltd. and Lupin Pharmaceuticals, Inc.. Service: 05/10/2024 by email. [1003632] [24-1766] [William Zimmerman] [Entered: 05/10/2024 05:56 PM] (3) |
May 1, 2024 | 1 | Appeal docketed. Received: 04/25/2024. [1001396]Entry of Appearance due 05/15/2024. Certificate of Interest is due on 05/15/2024. Docketing Statement due 05/15/2024. Appellants' brief is due 07/01/2024. [MMA] [Entered: 05/01/2024 03:44 PM] (43) |